NDC 49702-238 - Cabenuva
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 49702-238
- Package NDCs from labels
- 49702-238-01, 49702-238-64, 49702-238-03, 49702-238-61
- Manufacturer
- ViiV Healthcare Company | Glaxo Wellcome Manufacturing Pte. Ltd | Janssen Pharmaceutica NV
- Effective date
- 2025-11-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Cabenuva - ViiV Healthcare Company | Glaxo Wellcome Manufacturing Pte. Ltd | Janssen Pharmaceutica NV | ViiV Healthcare Company | Glaxo Wellcome Manufacturing Pte. Ltd | Janssen Pharmaceutica NV | 2025-11-26 | HUMAN PRESCRIPTION DRUG LABEL |
| Apretude - ViiV Healthcare Company | ViiV Healthcare Company | 2025-04-11 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 49702-238-01 | Cabenuva | 3 mL in 1 VIAL | INJECTION, SUSPENSION, EXTENDED | 1 mL | 200 mg in 1mL | 16 |
| 49702-238-64 | Cabenuva | 3 mL in 1 VIAL | INJECTION, SUSPENSION, EXTENDED | 1 mL | 200 mg in 1mL | 16 |
| 49702-238-03 | Apretude | 3 mL in 1 VIAL | INJECTION, SUSPENSION, EXTENDED | 3 mL | 200 mg in 1mL | 8 |
| 49702-238-61 | Apretude | 3 mL in 1 VIAL | INJECTION, SUSPENSION, EXTENDED | 3 mL | 200 mg in 1mL | 8 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 49702-238 | CABENUVA (CABOTEGRAVIR AND RILPIVIRINE) KIT [VIIV HEALTHCARE COMPANY] | 14 | Unmatched | 20250416_1698baf3-f895-4c42-a1b1-e9ee3f20da36.zip |
| 49702-238 | APRETUDE (CABOTEGRAVIR) KIT [VIIV HEALTHCARE COMPANY] | 8 | Unmatched | 20250419_4338428e-43d4-4e02-ac9d-bd98e738a7da.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DANGTTEOL | MINERAL WATER | AQBC CO., LTD | 27db14a9-3812-433f-e063-6394a90a11e7 | 2024-11-26 | Warnings | 059QF0KO0R |
| Potassium Citrate and Citric Acid | POTASSIUM CITRATE AND CITRIC ACID MONOHYDRATE | PAI Holdings, LLC dba PAI Pharma | ce42122f-8087-471f-b0a3-5524bdbd4526 | 2024-11-19 | Warnings, Adverse reactions | 2968PHW8QP |
| TRICITRATES | POTASSIUM CITRATE, SODIUM CITRATE, AND CITRIC ACID MONOHYDRATE | PAI Holdings, LLC dba PAI Pharma | 2ecb42a2-82f1-456b-8f1e-02c2d0a7b5ad | 2024-11-15 | Warnings, Adverse reactions | 2968PHW8QP |
| Sal de Uvas Picot | CITRIC ACID MONOHYDRATE AND SODIUM BICARBONATE | RB Health Mexico, S.A. de C.V. | 151b9bc9-1a6e-4401-ae58-4b4210ab4505 | 2024-11-15 | Warnings | 2968PHW8QP |
| Crane Safety Eye Wash | WATER SOLUTION | Crane Safety LLC | 96d8dda9-6cd6-3f68-e053-2995a90a0da2 | 2024-11-08 | Warnings | 059QF0KO0R |
| RUGBY EYE WASH | WATER, PURIFIED | A-S Medication Solutions | 0773e558-2f46-494c-888a-3bc517202b65 | 2024-11-08 | Warnings | 059QF0KO0R |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | BECTON DICKINSON AND COMPANY | d3f90d2f-4536-4d32-800b-7a798f8a35db | 2024-11-07 | Warnings, Adverse reactions | LX22YL083G |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 68cc9c41-ed24-4f76-8efb-2936ae3ddd8d | 2024-10-29 | Warnings, Adverse reactions | LX22YL083G |
| Lungex II | GINKGO BILOBA, COLON (SUIS), LUNG (SUIS), PANCREAS SUIS, GERMANIUM SESQUIOXIDE, CUPRUM METALLICUM, MANGANUM METALLICUM, STANNUM METALLICUM, ALPHA-KETOGLUTARICUM ACIDUM, CITRICUM ACIDUM, FUMARICUM ACIDUM, MALIC ACID, PYRUVIC ACID, SUCCINICUM ACIDUM, NAPHTHOQUINONE, ARSENICUM METALLICUM, CALCAREA CARBONICA, ACONITICUM ACIDUM, CIS, NATRUM OXALACETICUM, PHOSPHORUS | Energique, Inc. | ddf7fc46-95b7-44b4-b7ca-96a066a3fa2b | 2024-10-28 | Warnings | 2968PHW8QP |
| EyS Eye Wash | WATER | Eyes-Plus LLC | 1443f6bf-3a77-4a19-8585-0ec58efe042f | 2024-10-15 | Warnings | 059QF0KO0R |
| Eye Wash | WATER SOLUTION | Kroger Company | 354402ad-581d-47e7-9fd3-933bef281ff4 | 2024-10-11 | Warnings | 059QF0KO0R |
| Eye Wash | WATER | Hubei Changjian Medical Products Co., Ltd. | d57e1c5b-1edc-4a94-88bc-f9ecf347b7ea | 2024-10-11 | Warnings | 059QF0KO0R |
| teruflex blood bag system with diversion blood sampling arm 70 ml cpda-1 | ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, DEXTROSE MONOHYDRATE, AND ADENINE | Terumo Corporation | 86b3a329-c83f-4977-92f5-0e9dfe1872d7 | 2024-10-10 | Warnings | LX22YL083G 593YOG76RN |
| TERUFLEX BLOOD with Diversion Blood Sampling Arm 70 mL CPDA-1 | ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, DEXTROSE MONOHYDRATE, AND ADENINE | Terumo Corporation | 39f2e11c-5a31-469f-b725-d096c1674421 | 2024-10-03 | Warnings | LX22YL083G 593YOG76RN |
| Leader ClearLax | POLYETHYLENE GLYCOL 3350 | Cardinal Health 110, LLC. dba Leader | 9b759bd9-3818-4b71-a99c-aa7e202bf22e | 2024-10-01 | Warnings | G2M7P15E5P |
| TERUFLEX Blood Anticoagulant Citrate Phosphate Dextrose Adenine (CPDA-1) for Collection of 450mL of Blood | ANHYDROUS CITRIC ACID, TRISODIUM CITRATE DIHYDRATE, SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE, DEXTROSE MONOHYDRATE, AND ADENINE | Terumo Corporation | 02015040-9b71-4dbe-8f8d-e0d0951e8f93 | 2024-09-19 | Warnings | LX22YL083G 593YOG76RN |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | Fresenius Kabi USA, LLC | 3c5f0f65-8a54-4a55-ad4e-0f0be97631d7 | 2024-09-15 | Warnings, Adverse reactions | LX22YL083G |
| rugby PEG 3350 | POLYETHYLENE GLYCOL 3350 | Bryant Ranch Prepack | fb3f889c-7f88-4850-9994-d436f9010990 | 2024-09-06 | Warnings | G2M7P15E5P |
| Members Mark clearlax | POLYETHYLENE GLYCOL 3350 | Sam's West Inc | 5bc34a90-adc2-4031-b8a6-725829881550 | 2024-09-05 | Warnings | G2M7P15E5P |
| Dextrose | DEXTROSE MONOHYDRATE | FRESENIUS KABI USA, LLC | 576a22d8-5f2f-497e-80ad-1842ca74bb53 | 2024-08-22 | Warnings, Adverse reactions | LX22YL083G |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.